|
COQ3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.96979999999814E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.17430000000785E-05 |
| Normal-vs-Stage2 |
6.967300E-04 |
| Normal-vs-Stage3 |
5.80299999999312E-05 |
| Normal-vs-Stage4 |
8.881700E-02 |
| Stage1-vs-Stage2 |
8.122800E-01 |
| Stage1-vs-Stage3 |
2.311200E-01 |
| Stage1-vs-Stage4 |
4.642800E-01 |
| Stage2-vs-Stage3 |
4.562800E-01 |
| Stage2-vs-Stage4 |
3.741800E-01 |
| Stage3-vs-Stage4 |
1.794960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.23500000000088E-05 |
| Normal-vs-AfricanAmerican |
1.652370E-02 |
| Normal-vs-Asian |
2.356000E-04 |
| Caucasian-vs-AfricanAmerican |
8.679900E-02 |
| Caucasian-vs-Asian |
7.822800E-01 |
| AfricanAmerican-vs-Asian |
1.069010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00599999950124E-07 |
| Normal-vs-Female |
5.980400E-03 |
| Male-vs-Female |
3.073000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.021440E-03 |
| Normal-vs-Extreme_Weight |
9.86120000101565E-08 |
| Normal-vs-Obese |
1.900130E-03 |
| Normal-vs-Extreme_Obese |
5.151000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.630400E-01 |
| Normal_Weight-vs-Obese |
9.404000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.448000E-01 |
| Extreme_Weight-vs-Obese |
6.033400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.098800E-01 |
| Obese-vs-Extreme_Obese |
4.002000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.121400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.797800E-04 |
| Normal-vs-Age(61-80Yrs) |
4.54469999999763E-06 |
| Normal-vs-Age(81-100Yrs) |
9.002100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.402800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.430800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.462000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.815200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.063800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.817600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.213100E-04 |
| Normal-VS-Type2 PRCC |
3.02360000004054E-06 |
| Normal-VS-KIRP CIMP |
1.803630E-04 |
| Normal-VS-Unclassified PRCC |
2.90999999996711E-06 |
| Type1 PRCC-VS-Type2 PRCC |
8.560000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.371900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.577800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.872800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.758400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.349000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0856000000059E-06 |
| Normal-vs-N1 |
9.78870000000187E-05 |
| Normal-vs-N2 |
1.480020E-03 |
| N0-vs-N1 |
9.863600E-01 |
| N0-vs-N2 |
1.390830E-01 |
| N1-vs-N2 |
1.677030E-01 |
|
|
